| MYF5 |
MYF5: Myogenic factor 5 |
RYR1 |
|
3.862 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
3.862 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
ROCK2 |
ROCK2, KIAA0619: Rho-associated protein kinase 2 |
3.862 |
Evidence |
|
| KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
3.862 |
Evidence |
|
| KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
FOXO1A |
FOXO1A, FKHR: Forkhead box protein O1A |
3.862 |
Evidence |
|
| BMX |
IPI00514142 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
3.862 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
3.862 |
Evidence |
|
| STIP1 |
STIP1: Stress-induced-phosphoprotein 1 |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
3.862 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
CASR |
CASR, GPRC2A, PCAR1: Extracellular calcium-sensing receptor precursor |
3.862 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
PBK |
PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase |
3.862 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
CASR |
CASR, GPRC2A, PCAR1: Extracellular calcium-sensing receptor precursor |
3.862 |
Evidence |
|
| EPOR |
EPOR: Erythropoietin receptor precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
3.862 |
Evidence |
|
| ITGB4 |
IPI00027422 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
3.862 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
3.862 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
F5 |
F5: Coagulation factor V precursor |
3.862 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
3.862 |
Evidence |
|
| AMBP |
AMBP, HCP, ITIL: AMBP protein precursor [Contains: Alpha-1-microglobulin |
ACE |
ACE, DCP, DCP1: Angiotensin-converting enzyme, testis-specific isoform precursor |
3.862 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
F3 |
F3: Tissue factor precursor |
3.862 |
Evidence |
|
| LTA |
LTA, TNFB, TNFSF1: Lymphotoxin-alpha precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
3.862 |
Evidence |
|
| TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
EGF |
EGF: Pro-epidermal growth factor precursor |
3.862 |
Evidence |
|
| MDM4 |
MDM4, MDMX: Mdm4 protein |
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
3.862 |
Evidence |
|
| IKBKB |
IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
3.862 |
Evidence |
|
| CDC23 |
CDC23: Cell division cycle protein 23 homolog |
MARK2 |
IPI00718858 |
3.855 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
PTMA |
IPI00015550 |
3.855 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
NCOA3 |
IPI00220082 |
3.855 |
Evidence |
|